Acute Myeloid Leukemia Clinical Trials

A listing of Acute Myeloid Leukemia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

UPDATED

Gilbert Arizona

Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML

California

UPDATED

Duarte California 91010

Patients are needed to participate in a clinical research study evaluating Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody and Guadecitabine for the treatment of Acute Myeloid Leukemia

UPDATED

Duarte California 91010

Patients are needed to participate in a clinical research study of AGS62P1 to evaluate Acute Myeloid Leukemia

Connecticut

UPDATED

New Haven Connecticut 06511

Patients are needed to participate in a clinical research study evaluating Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody and Guadecitabine for the treatment of Acute Myeloid Leukemia

UPDATED

New Haven Connecticut

Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML

Florida

UPDATED

Jacksonville Florida 32204

Patients are needed to participate in a clinical research study of ASP2215 and Placebo to evaluate Acute Myeloid Leukemia (AML) or Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation

Georgia

UPDATED

Atlanta Georgia 30342

A clinical trial to evaluate treatments using Alvocidib, Cytarabine and Mitoxantrone for patients with Acute Myeloid Leukemia (AML)

Illinois

UPDATED

Maywood Illinois

Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML

Iowa

UPDATED

Iowa City Iowa 52242

A clinical trial to evaluate treatments using Alvocidib, Cytarabine and Mitoxantrone for patients with Acute Myeloid Leukemia (AML)

UPDATED

Sioux City Iowa 51101

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Kansas

UPDATED

Westwood Kansas 66205

Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML

Louisiana

UPDATED

New Orleans Louisiana 70112

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

UPDATED

New Orleans Louisiana 70121

A clinical trial to evaluate treatments using Alvocidib, Cytarabine and Mitoxantrone for patients with Acute Myeloid Leukemia (AML)

Maryland

UPDATED

Baltimore Maryland 21287

A clinical trial to evaluate treatments using Alvocidib, Cytarabine and Mitoxantrone for patients with Acute Myeloid Leukemia (AML)

UPDATED

Baltimore Maryland 21287

Patients are needed to participate in a clinical research study of AGS62P1 to evaluate Acute Myeloid Leukemia

Minnesota

UPDATED

Minneapolis Minnesota 55407

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Missouri

UPDATED

St. Louis Missouri 63110

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

New Mexico

UPDATED

Albuquerque New Mexico 87131

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

New York

UPDATED

Lake Success New York 11042

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

UPDATED

New York New York 10032

A clinical trial to evaluate treatments using Alvocidib, Cytarabine and Mitoxantrone for patients with Acute Myeloid Leukemia (AML)

UPDATED

New York New York 10032

Patients are needed to participate in a clinical research study evaluating Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody and Guadecitabine for the treatment of Acute Myeloid Leukemia

UPDATED

New York New York 10016

Patients are needed to participate in a clinical research study of AGS62P1 to evaluate Acute Myeloid Leukemia

UPDATED

New York New York 10016

Patients are needed to participate in a clinical research study of ASP2215 and Placebo to evaluate Acute Myeloid Leukemia (AML) or Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation

View More ▼

UPDATED

New York New York 10065

Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML

North Carolina

UPDATED

Chapel Hill North Carolina 27599

A clinical trial to evaluate treatments using Alvocidib, Cytarabine and Mitoxantrone for patients with Acute Myeloid Leukemia (AML)

UPDATED

Charlotte North Carolina 28204

Patients are needed to participate in a clinical research study evaluating Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody and Guadecitabine for the treatment of Acute Myeloid Leukemia

Ohio

UPDATED

Canton Ohio 44718

Patients are needed to participate in a clinical research study of ASP2215 and Placebo to evaluate Acute Myeloid Leukemia (AML) or Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation

UPDATED

Cleveland Ohio

Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML

Oregon

UPDATED

Portland Oregon 97239

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

UPDATED

Portland Oregon 97239

A clinical trial to evaluate treatments using BPX-701 and Rimiducid for patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

Pennsylvania

UPDATED

Hershey Pennsylvania

Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML

South Dakota

UPDATED

Sioux Falls South Dakota 57105

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Tennessee

UPDATED

Nashville Tennessee 37203

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Texas

UPDATED

Dallas Texas 75246

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

UPDATED

Dallas Texas 75246

A clinical trial to evaluate treatments using Alvocidib, Cytarabine and Mitoxantrone for patients with Acute Myeloid Leukemia (AML)

UPDATED

Dallas Texas

Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML

UPDATED

Houston Texas 77030

A clinical research study for the treatment of Leukemia, Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome

UPDATED

Houston Texas 77030

A clinical research study of Nivolumab for the treatment of Leukemia or Acute Myeloid Leukemia (AML)

View More ▼

UPDATED

Houston Texas 77030

A clinical trial seeking patients for a research study for the treatment of Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia or Acute Myeloid Leukemia

UPDATED

Houston Texas 77030

A clinical trial to evaluate treatments using Alvocidib, Cytarabine and Mitoxantrone for patients with Acute Myeloid Leukemia (AML)

UPDATED

Houston Texas 77030

Patients are needed to participate in a clinical research study of AGS62P1 to evaluate Acute Myeloid Leukemia

UPDATED

Houston Texas

Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML

Utah

UPDATED

Salt Lake City Utah 84112

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

UPDATED

Salt Lake City Utah 84132-0001

Patients are needed to participate in a clinical research study evaluating Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody and Guadecitabine for the treatment of Acute Myeloid Leukemia

Virginia

UPDATED

Arlington Virginia 22031

Patients are needed to participate in a clinical research study of ASP2215 and Placebo to evaluate Acute Myeloid Leukemia (AML) or Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation

Washington

UPDATED

Seattle Washington 98122

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

UPDATED

Seattle Washington

Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML

Wisconsin

UPDATED

Madison Wisconsin 53705

Patients are needed to participate in a clinical research study evaluating Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody and Guadecitabine for the treatment of Acute Myeloid Leukemia

Belgium

UPDATED

Brugge 8000

A Phase 2 clinical study for patients with Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

UPDATED

Brussels 1000

A Phase 2 clinical study for patients with Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome